A clinical-stage biotechnology company established by The University of Queensland and Emory University (Atlanta, USA) to develop novel cancer supportive care and anticancer therapies has raised US$16 million in series A investment.
6 June 2017
A chronic pain treatment discovered at The University of Queensland is a step closer to clinical use with a global pharmaceutical giant acquiring the Australian-founded company developing the drug.
29 June 2015
An Australian company developing a chronic pain treatment based on research at The University of Queensland (UQ) has attracted US$45 million (AU$48M) to advance development of the drug, EMA401.
11 April 2014
